For: | Li YC, Yang CS, Zhou WL, Li HS, Han YJ, Wang QS, Wu HB. Low glucose metabolism in hepatocellular carcinoma with GPC3 expression. World J Gastroenterol 2018; 24(4): 494-503 [PMID: 29398870 DOI: 10.3748/wjg.v24.i4.494] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v24/i4/494.htm |
Number | Citing Articles |
1 |
Kunal Ramesh Chandekar, Arun Prashanth, Sobhan Vinjamuri, Rakesh Kumar. FAPI PET/CT Imaging—An Updated Review. Diagnostics 2023; 13(12): 2018 doi: 10.3390/diagnostics13122018
|
2 |
Angelo Castello, Egesta Lopci. Imaging HCC treated with radioembolization: review of the literature and clinical examples of choline PET utility. Clinical and Translational Imaging 2020; 8(5): 377 doi: 10.1007/s40336-020-00384-y
|
3 |
Bin Yi, Tian Wu, Nan Zhu, Yao Huang, Xiaoyu Yang, Lei Yuan, Yingjun Wu, Xiaofei Liang, Xiaoqing Jiang. The clinical significance of CTC enrichment by GPC3-IML and its genetic analysis in hepatocellular carcinoma. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-00818-3
|
4 |
Shuai Huang, Kai Luo, Li Jiang, Xu-Dong Zhang, Ying-Hao Lv, Ren-Feng Li. PCBP1 regulates the transcription and alternative splicing of metastasis‑related genes and pathways in hepatocellular carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-02642-z
|
5 |
Mikhail Kesler, Charles Levine, Dov Hershkovitz, Eyal Mishani, Yoram Menachem, Hedva Lerman, Yaniv Zohar, Oren Shibolet, Einat Even-Sapir. 68Ga-Labeled Prostate-Specific Membrane Antigen Is a Novel PET/CT Tracer for Imaging of Hepatocellular Carcinoma: A Prospective Pilot Study. Journal of Nuclear Medicine 2019; 60(2): 185 doi: 10.2967/jnumed.118.214833
|
6 |
Monica Mossenta, Davide Busato, Michele Dal Bo, Giuseppe Toffoli. Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies. Cancers 2020; 12(6): 1668 doi: 10.3390/cancers12061668
|
7 |
Trinh Nguyen, Jaijo Vennatt, Lincoln Downs, Venkateswar Surabhi, Nir Stanietzky. Advanced Imaging of Hepatocellular Carcinoma: A Review of Current and Novel Techniques. Journal of Gastrointestinal Cancer 2024; 55(4): 1469 doi: 10.1007/s12029-024-01094-8
|
8 |
Laura Evangelista, Paolo Artoli, Paola Bartoletti, Antonio Bignotto, Federica Menegatti, Marco Frigo, Stefania Antonia Sperti, Laura Vendramin, Diego Cecchin. Radiology‐Nuclear Medicine Diagnostic Imaging. 2023; : 788 doi: 10.1002/9781119603627.ch29
|
9 |
Shiori Meguro, Daisuke Suzuki, Toru Kawai, Takanori Kyokane, Yoichiro Aoshima, Yasunori Enomoto, Haruna Yagi, Hideya Kawasaki, Isao Kosugi, Hiroe Tsukui, Satoshi Baba, Toshihide Iwashita. A case of an alpha-fetoprotein-producing gastric so-called carcinosarcoma with enteroblastic differentiation. Human Pathology: Case Reports 2020; 22: 200420 doi: 10.1016/j.ehpc.2020.200420
|
10 |
Woo-Ri Shin, Dae-Young Park, Ji Hun Kim, Jin-Pyo Lee, Nguyen Quang Thai, In-Hwan Oh, Simranjeet Singh Sekhon, Wooil Choi, Sung Yeon Kim, Byung-Kwan Cho, Sun Chang Kim, Jiho Min, Ji-Young Ahn, Yang-Hoon Kim. Structure based innovative approach to analyze aptaprobe–GPC3 complexes in hepatocellular carcinoma. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01391-z
|
11 |
Yuriko Mori, Emil Novruzov, Dominik Schmitt, Jens Cardinale, Tadashi Watabe, Peter L. Choyke, Abass Alavi, Uwe Haberkorn, Frederik L. Giesel. Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET). npj Imaging 2024; 2(1) doi: 10.1038/s44303-024-00053-z
|
12 |
Pietro Zucchetta, Carmelo Lacognata, Francesca Girardi, Alessandro Spimpolo, Filippo Crimì, Giulio Cabrelle, Chiara Zanon, Patrizia Boccagni, Laura Evangelista, Diego Cecchin, Umberto Cillo. [18F]FDG PET/MRI in the follow-up of hepatocellular carcinoma after liver transplantation. Nuclear Medicine Communications 2022; 43(3): 359 doi: 10.1097/MNM.0000000000001518
|
13 |
Ren-Cai Lu, Bo She, Wen-Tao Gao, Yun-Hai Ji, Dong-Dong Xu, Quan-Shi Wang, Shao-Bo Wang. Positron-emission tomography for hepatocellular carcinoma: Current status and future prospects. World Journal of Gastroenterology 2019; 25(32): 4682-4695 doi: 10.3748/wjg.v25.i32.4682
|
14 |
Gebing Yao, Jikai Yin, Qing Wang, Rui Dong, Jianguo Lu. Glypican-3 Enhances Reprogramming of Glucose Metabolism in Liver Cancer Cells. BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/2560650
|
15 |
Youcai Li, Yin Zhang, Qi Fang, Xiaoyao Zhang, Peng Hou, Hubing Wu, Xinlu Wang. Radiomics analysis of [18F]FDG PET/CT for microvascular invasion and prognosis prediction in very-early- and early-stage hepatocellular carcinoma. European Journal of Nuclear Medicine and Molecular Imaging 2021; 48(8): 2599 doi: 10.1007/s00259-020-05119-9
|
16 |
Kevser Oksuzoglu, Tunc Ones, Salih Ozguven, Sabahat Inanir, Halil Turgut Turoglu, Emine Bozkurtlar, Cigdem Ataizi Celikel, Tanju Yusuf Erdil. Change in standardized uptake values in delayed 18F-FDG positron emission tomography images in hepatocellular carcinoma. Medicine 2018; 97(42): e12817 doi: 10.1097/MD.0000000000012817
|
17 |
Esther Mena, Joanna Shih, Joon-Yong Chung, Jennifer Jones, Atoosa Rabiee, Cecilia Monge, Baris Turkbey, Liza Lindenberg, Kilian E. Salerno, Michael Kassin, Brad Wood, Jonathan Hernandez, Roberto Maass-Moreno, Babak Saboury, Neha Jakhete, Jason K. Molitoris, Keith R. Unger, Peter L. Choyke, Freddy E. Escorcia, Johannes Stortz. Functional Imaging of Liver Cancer (FLIC): Study protocol of a phase 2 trial of 18F-DCFPyL PET/CT imaging for patients with hepatocellular carcinoma. PLOS ONE 2022; 17(11): e0277407 doi: 10.1371/journal.pone.0277407
|
18 |
Qianhui Dou, Aaron K. Grant, Patricia Coutinto de Souza, Marwan Moussa, Imad Nasser, Muneeb Ahmed, Leo L. Tsai. Characterizing Metabolic Heterogeneity of Hepatocellular Carcinoma with Hyperpolarized 13C Pyruvate MRI and Mass Spectrometry. Radiology: Imaging Cancer 2024; 6(2) doi: 10.1148/rycan.230056
|
19 |
Kashif Rafiq Zahid, Shun Yao, Abdur Rehman Raza Khan, Umar Raza, Deming Gou. mTOR/HDAC1 Crosstalk Mediated Suppression of ADH1A and ALDH2 Links Alcohol Metabolism to Hepatocellular Carcinoma Onset and Progression in silico. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01000
|
20 |
Hao Yang, Jingyi Wang, Gang Huang. Small extracellular vesicles in metabolic remodeling of tumor cells: Cargos and translational application. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1009952
|